Fed Near Neutral Signals Caution Ahead, Shifting Focus to Fixed Income in 2026 
Asia’s IPO Market Set for Strong Growth as China and India Drive Investor Diversification 
Austria’s AA Credit Rating Affirmed as Fitch Highlights Stable Outlook 
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 
Bitcoin Reserves Hit 5-Year Low as $2.15B Exits Exchanges – Bulls Quietly Loading the Spring Below $100K 
By purchasing 760,190 SOL tokens valued at $167 million, Helius Medical Technologies has made a strategic shift from neurotechnology to become a significant Solana treasury business. With an average price of $231 per token, Solana is the second-biggest public holder after Forward Industries, following a $500 million private placement. Under the guidance of Pantera Capital and Summer Capital, NASDAQ-listed firm HSDT has kept almost $335 million in cash for upcoming purchases while positioning itself among the emerging group of businesses using Solana for treasury management, including DeFi Development Corp and Upexi. Because of its 7% native staking return, better transaction processing capacity of more than 3,500 transactions per second, and development, representing a larger corporate treasury revolution whereby businesses are spreading beyond conventional assets into yield-generating digital assets, the DeFi ecosystem offers several revenue-generating opportunities.
Market Movements: Navigating the Price Trends of SOL
The SOL/USD declined more than 15% following the footsteps of BTC. Near-term support is identified at $200, with a drop below this level potentially leading to targets of $180/$140/$123/$117/$100. Immediate resistance is noted at around $225, where a breach could push prices up to $265/$300, or even $350.
It is good to buy on dips around $200, with a stop-loss set at $160 and a target price of $300/$350.
